-
Featured
Novel Therapeutic May Prevent Mitral Valve Damage After Heart Attack
Damage to the mitral valve after heart attack leads to HF and death. Treatment with hypertension drug may reduce mitral valve scaring and stiffening.
-
Featured
Left Ventricular-Mitral Valve Ring Ratio May Predict Recurrent Mitral Regurgitation
Researchers found that a mismatch in left ventricular and mitral valve ring size can predict whether a patient is at a higher risk of recurrent mitral regurgitation after mitral valve repair.
-
Featured
Cardiac CT Mechanical Valve Prosthesis Dysfunction Diagnosis
A 27-year-old woman with history of type 1 truncus arteriosus presented with several months of progressive dyspnea for subspecialty ACHD care.
-
Application of Bioadhesive to Heart Improves Survival in Preclinical Model of Myocardial Infarction
Telemachus & Irene Demoulas Family Foundation Center for Cardiac Arrhythmias researchers have formulated a gelatin-based bioadhesive that can be applied in liquid form to the site of myocardial infarction, then polymerized with visible-spectrum light, rapidly creating a firm but flexible scaffold to support weakened tissue and preserve left ventricular function.
-
Cerebral Embolic Protection Device May Not Reduce Stroke Risk After Transcatheter Aortic Valve Implantation
Dhaval Kolte, MD, PhD, and Sammy Elmariah, MD, MPH, and colleagues determined from a nationally representative database that using a cerebral embolic protective device during transcatheter aortic valve implantation was not associated with lower rates of in-hospital stroke, transient ischemic attack or mortality.
-
Review: Optimal Anticoagulation After Bioprosthetic Valve Replacement
Massachusetts General Hospital researchers review medical society guidelines about anticoagulation and antiplatelet therapy after bioprosthetic aortic and mitral valve replacement—and propose their own strategies.
Valvular Heart Disease Contributors
-
Jacob Dal-Bianco, MD
Cardiologist
Recent Article
Novel Therapeutic May Prevent Mitral Valve Damage After Heart Attack
-
Judy Wei-Ming Hung, MD
Director of the Echocardiography Lab, Division of Cardiology, Professor of Medicine, Harvard Medical School
Recent Article
Tricuspid Regurgitation Uncommon After Surgery for Ischemic Mitral Regurgitation But Tied to Cardiac Events
-
Robert A. Levine, MD
Senior Physician, Cardiac Ultrasound Laboratory
Recent Article
Cilia Defects During Fetal Development Can Cause Mitral Valve Prolapse -
Serguei Melnitchouk, MD, MPH
Cardiac Surgeon, Co-Director, Heart Valve Program, Quality Director, Division of Cardiac Surgery
Recent Article
Review: Optimal Anticoagulation After Bioprosthetic Valve Replacement
-
Thoralf M. Sundt, MD
Chief, Division of Cardiac Surgery, Director, Corrigan Minehan Heart Center
Recent Article
Non–Vitamin K Antagonist Oral Anticoagulants Are Safe for Selected Patients with Postoperative AF
Cardiovascular Care at Mass General
At Mass General, our world-class physicians and nurses specialize in specific forms of both heart and vascular disease, and work closely together to offer leading treatments and preventive care for cardiovascular conditions.Resource links
